Skip Navigation

JNCI Journal of the National Cancer Institute 2000 92(24):1968-1969; doi:10.1093/jnci/92.24.1968
© 2000 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Nelson, N. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nelson, N. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 92, No. 24, 1968-1969, December 20, 2000
© 2000 Oxford University Press

NEWS

Trial Data Lacking For Elderly Patients With Breast Cancer

Nancy J. Nelson

In November, a National Institutes of Health consensus panel evaluated which therapies are effective in preventing the spread of microscopic deposits of cancer cells after surgical removal of an early-stage breast tumor. The panel recommended that most women receive standard adjuvant treatments after surgery—radiation with hormonal therapy and/or chemotherapy.

Those largely left out of the recommendations, however, are women over 70 years old. The reason for this omission is simple: There are very few completed randomized trials with enough women age 70 or older to evaluate the relative benefits and morbidity of adjuvant therapies.

The pressing need for these data was advanced by Hyman B. Muss, M.D., associate director of the Vermont Cancer Center and one of the speakers at the consensus conference. Not only do elderly . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ann OncolHome page
P. Harter, A. du Bois, C. Schade-Brittinger, A. Burges, K. Wollschlaeger, M. Gropp, B. Schmalfeldt, J. Huober, A. Staehle, J. Pfisterer, et al.
Non-enrolment of ovarian cancer patients in clinical trials: reasons and background
Ann. Onc., November 1, 2005; 16(11): 1801 - 1805.
[Abstract] [Full Text] [PDF]